Hexasprees (Hexaspray)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceBiclotimoleBiclotimole
Similar drugsTo uncover
  • Hexasprees
    aerosol locally 
    Bouchard-Recordati Laboratories     France
    • Dosage form: & nbspaerosol for topical use
    Composition:

    For 1 bottle (30 g):

    Active substance:


    Biclotimole

    0.75 g

    Excipients:


    Gasoline alcohol

    0.5 g

    Disodium Edetate

    0.0025 grams

    Methylparahydroxybenzoate

    0.025 g

    Anise ordinary seed oil

    0.03 g

    Ammonium glycyrrhizinate

    0.02 g

    Sodium saccharinate

    0.05 g

    Avicel RC 591 (Microcrystalline cellulose and carmellose sodium)

    0.3 g

    Soy lecithin

    0.9 g

    Glycerol

    1.0 g

    Ethanol 96%

    1.06 g

    Water

    up to 30,0 g
    Description:Homogeneous, white with a yellowish hue of color suspension, with a characteristic smell of anise.
    Pharmacotherapeutic group:Antimicrobial agent
    ATX: & nbsp

    R.02.A.A   Antiseptics

    Pharmacodynamics:

    Has an antimicrobial effect (active against Staphylococcus spp., Streptococcus spp., Corynebacterium spp.). The mechanism of action is due to the coagulation of the proteins of the microbial cell. Has analgesic and anti-inflammatory effect.

    Pharmacokinetics:

    Slowly absorbed through the mucous membrane of the mouth, has a prolonged local effect.

    Indications:

    Infectious-inflammatory diseases of the oral cavity (including stomatitis, gingivitis), pharynx, larynx caused by biklotimol-sensitive pathogens.

    Local treatment of inflammatory and infectious diseases of the nasopharynx and respiratory tract (acute and chronic pharyngitis, pharyngolaringitis, tonsillitis,states after tonsillectomy, glossitis).

    Contraindications:

    Children under 6 years.

    Hypersensitivity to the components of the drug.

    Pregnancy and lactation:

    Adequate and strictly controlled studies of the safety of the drug during pregnancy and lactation were not conducted.

    In pregnancy and lactation, use is possible if the potential benefit to the mother exceeds the possible risk to the fetus and the baby.

    Dosing and Administration:

    Locally: 2 doses of aerosol 3 times a day, regardless of food intake.

    The duration of treatment should not exceed 10 days. If it is necessary to continue treatment for a longer period, consult a doctor.

    Side effects:

    Local allergic reactions are possible.

    In case of unusual reactions, consult a doctor about the advisability of further use of the drug.

    Overdose:

    No data on overdose cases.

    Interaction:Avoid simultaneous use of other local funds.
    Special instructions:

    During use, the bottle should be held vertically. Shake the bottle before use (see Fig.).

    Effect on the ability to drive transp. cf. and fur:

    There is no evidence of a negative effect of the drug on the ability to drive and other vehicles.

    Form release / dosage:

    Aerosol for topical use, 2.5%.

    Packaging:

    To 30 g in a glass bottle (type of glass 3), covered from the outside with plastic (PVC), closed with a plastic lid with a spray valve.

    One bottle together with the instruction for use is placed in a cardboard box.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    5 years.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N006694
    Date of registration:24.08.2010 / 09.09.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:Bouchard-Recordati LaboratoriesBouchard-Recordati Laboratories France
    Manufacturer: & nbsp
    Representation: & nbspRUSFIK LLC RUSFIK LLC Russia
    Information update date: & nbsp17.03.2017
    Illustrated instructions
    Instructions
    Up